San Francisco Drug Treatment Center

San Francisco Drug Treatment Center – www.altamirarecovery.com

The Ticker

Filed under: drug treatment programs in san francisco

Cambridge-based Aegerion Pharmaceuticals Inc. won U.S. Food and Drug Administration approval for its cholesterol drug Juxtapid, which is designed to treat patients suffering from the rare genetic disease homozygous familial hypercholesterolemia. The …
Read more on Boston Herald